Virios Therapeutics Inc/$DWTX
1D1W1MYTD1Y5YMAX
Capital at risk
About Virios Therapeutics Inc
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
- Ticker
- $DWTX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Alpharetta, United States
- Website
- dwtx.com
DWTX Metrics
BasicAdvanced
$50M
-
-$1.71
1.76
-
Price and volume
Market cap
$50M
Beta
1.76
52-week high
$7.20
52-week low
$1.28
Average daily volume
74K
Financial strength
Current ratio
3.894
Quick ratio
3.394
Long term debt to equity
0.001
Total debt to equity
0.002
Profitability
EBITDA (TTM)
-29.559
Effective tax rate (TTM)
6.36%
Management effectiveness
Return on assets (TTM)
-20.83%
Return on equity (TTM)
-47.77%
Valuation
Price to book
0.72
Price to tangible book (TTM)
0.71
Price to free cash flow (TTM)
-2.035
Free cash flow yield (TTM)
-49.14%
Free cash flow per share (TTM)
-0.718
Growth
Earnings per share change (TTM)
-90.66%
3-year earnings per share growth (CAGR)
-47.42%
DWTX Financial Performance
Revenues and expenses
DWTX Earnings Performance
Company profitability
Upcoming events
No upcoming events
DWTX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.